Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03064204 · ClinicalTrials.gov registry record
The Pathogenesis of OSA in People Living With HIV
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 34
- Enrollment target
NCT03064204: Completed study, sponsored by University of California, San Diego.
NCT03064204 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03064204 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to help us understand how HIV and/or Anti-Retroviral Therapy (ART) may predispose individuals to Obstructive Sleep Apnea (OSA). The traditional risk factors for OSA are weight and age. However, people living with HIV on ART seem to have OSA even when they are thin and young. The study involves a detailed physiological sleep study and an MRI of the head and neck to understand the underlying cause of OSA in those with and without HIV.
Primary Outcome
Upper airway collapsibility, as assessed by rapid withdrawal of PAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2017-02-09 |
| Est. Completion | 2020-11-04 |
What the finished NCT03064204 record still lists
NCT03064204 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03064204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03064204 about?
NCT03064204 is a clinical study titled "The Pathogenesis of OSA in People Living With HIV". The purpose of this study is to help us understand how HIV and/or Anti-Retroviral Therapy (ART) may predispose individuals to Obstructive Sleep Apnea (OSA). The traditional risk factors for OSA are weight and age. However, people living with HIV on ART seem to have OSA even when they are thin and yo...
What is the current status of trial NCT03064204?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2017-02-09. Estimated completion is 2020-11-04.
Who is sponsoring clinical trial NCT03064204?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI